VIRS

Pacer BioThreat Strategy ETF
VIRS

Delisted

VIRS was delisted on the 10th of October, 2024.

Back to rankings

6 hedge funds and large institutions have $1.87M invested in Pacer BioThreat Strategy ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$58.8K
2
+$21.9K
3
+$2K
4
Morgan Stanley
Morgan Stanley
New York
+$48

Top Sellers

1
-$11.3K
2
-$4.82K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$775K
2
$667K
3
$327K
4
$94K
5
$3.05K
6
$48
7
–